Early tumor shrinkage as a predictor of favorable outcomes in patients with advanced pancreatic cancer treated with FOLFIRINOX

There are several reports on the correlation between early tumor shrinkage (ETS) or depth of response (DpR) and survival in chemotherapies for colorectal cancer; however, few studies have investigated it in pancreatic cancer. We therefore investigated whether the ETS will predict outcomes in 59 pati...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Oncotarget Ročník 7; číslo 41; s. 67314 - 67320
Hlavní autori:	Kaga, Yasuhiro, Sunakawa, Yu, Kubota, Yutaro, Tagawa, Teppei, Yamamoto, Taikan, Ikusue, Toshikazu, Uto, Yu, Miyashita, Kouichirou, Toshima, Hirokazu, Kobayashi, Kouji, Hisamatsu, Atsushi, Ichikawa, Wataru, Sekikawa, Takashi, Shimada, Ken, Sasaki, Yasutsuna
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 11.10.2016
Predmet:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Disease-Free Survival Female Humans Kaplan-Meier Estimate Male Middle Aged Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - mortality Pancreatic Neoplasms - pathology Prognosis Treatment Outcome FOLFIRINOX pancreatic cancer early tumor shrinkage
ISSN:	1949-2553
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!